Position
Creative Planning in Olema Pharmaceuticals, Inc.
Back to the book · All holders of OLMA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$652.4K$25.00 → $14.91
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 64.7K | $1.62M | — | — | — | 0.0% |
| Q1 2026 | 72.2K | $1.08M | $14.91 | −$652.4K | $113K | 0.0% |